Cohort two of the programme was also launched at the event along with an announcement of plans for participating companies Dario Health and Agamon to visit London on 1-3 July.
The London visit, hosted by DigitalHealth.London, will see Dario Health and Agamon present their innovative digital health solutions to leading NHS England and UK health-tech decision makers while learning more about the UK health system.
NASDAQ-listed Dario Health provides people living with chronic or pre-chronic conditions such as Diabetes with a personalized, data-driven experience to improve their lifestyle and health outcomes.
Agamon, a healthcare intelligence platform and late-stage start-up, provides tools and services for a faster, more efficient and scalable way to access high quality healthcare data and insights, initially focusing on structuring radiological reports.
Masood Ahmed, Senior Advisor at DigitalHealth.London attended the showcase demonstration evening in Tel Aviv and commented: “It’s easy to understand how the rich culture of innovation has flourished in this environment. This was an amazing showcase of cutting-edge ideas hosted by the IBM Alpha Zone Accelerator. It was wonderful for DigitalHealth.London and the UK-Israel Tech Hub to be recognised by IBM leadership and innovators for our work with cohort one companies DayTwo, Neurotech Solutions and Orpheus Medical. We very much look forward to working with Dario Health and Agamon on cohort two of this programme.”
DigitalHealth.London is a collaborative programme delivered by MedCity and UCLPartners, Imperial College Health Partners, and the Health Innovation Network.
The UK-Israel Dangoor Health Initiative is a partnership between the UK-Israel Tech Hub; IBM Alpha Zone; Dangoor Education and DigitalHealth.London.
For more information about the UK Israel Dangoor Health Initiative, visit the DigitalHealth.London website.
Read Charlie Davie’s blog on why a global perspective is key in health innovation.